I am not reading/hearing it that way, but would prefer your 38.2m.
The backlog is 23m, which would include the 7.5m of new SPS orders. As the 23m backlog is going to be completed within the FY, only the 3.7m of revenue from Q1 can be added.
26.5m rounded up to 27m, additional sales are needed to fill the gap to 35m.
- Forums
- ASX - By Stock
- FLC
- Ann: Fluence Business Update for Q1 2021
Ann: Fluence Business Update for Q1 2021, page-34
-
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FLC (ASX) to my watchlist
|
|||||
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $108.0M |
Open | High | Low | Value | Volume |
10.0¢ | 10.0¢ | 9.5¢ | $141.4K | 1.419M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 9.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.5¢ | 100000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 0.097 |
1 | 100000 | 0.095 |
1 | 5799 | 0.092 |
2 | 147490 | 0.090 |
1 | 1176 | 0.085 |
Price($) | Vol. | No. |
---|---|---|
0.105 | 100000 | 1 |
0.110 | 185514 | 3 |
0.115 | 115012 | 3 |
0.120 | 260053 | 3 |
0.130 | 75364 | 3 |
Last trade - 15.59pm 13/08/2024 (20 minute delay) ? |
Featured News
FLC (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online